or Try an Advanced Search...

    Central Nervous System Disorders Stocks List

    Symbol Grade Name % Change
    PRTC B PureTech Health plc 1.79
    PRAX B Praxis Precision Medicines, Inc. 0.70
    VNDA B Vanda Pharmaceuticals Inc. 4.27
    AXSM C Axsome Therapeutics, Inc. 0.82
    PASG D Passage Bio, Inc. -2.24
    NGNE D Neurogene, Inc. 3.50
    DRRX D DURECT Corporation 17.17
    IRWD F Ironwood Pharmaceuticals, Inc. -2.17
    ACAD F ACADIA Pharmaceuticals Inc. -0.18
    BEAM F Beam Therapeutics Inc. 1.80
    View As Page of Charts
    Related Industries: Biotechnology Conglomerates Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Nervous System Disorders Biopharmaceutical Schizophrenia Alzheimer's Disease Biotechnology Chemical Compounds Chronic Pain Depression Cardiovascular Disease Chronic Disease Clinical Development Depressive Disorder Gastrointestinal Gene Therapy Major Depressive Disorder Medication Medicine Organ Systems Organic Compounds Pain

    Related ETFs - A few ETFs which own one or more of the above listed Central Nervous System Disorders stocks.

    Symbol Grade Name Weight
    FBT D First Trust Amex Biotech Index Fund 6.32
    SBIO D ALPS Medical Breakthroughs ETF 5.28
    XPH D SPDR S&P Pharmaceuticals ETF 4.86
    BBP D BioShares Biotechnology Products Fund 4.78
    PILL D Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 4.03
    View all Central Nervous System Disorders ETFs...
    Compare ETFs
    Compare BBP to PILL Compare FBT to XPH Compare XPH to BBP

        Central Nervous System Disorders Stocks Recent News

        Date Stock Title
        May 3 AXSM Axsome Therapeutics Q1 2024 Earnings Preview
        May 3 AXSM Should You Buy Axsome Therapeutics (AXSM) Ahead of Earnings?
        May 2 BEAM Ultragenyx (RARE) Reports Q1 Loss, Lags Revenue Estimates
        May 2 IRWD Earnings Preview: Ironwood Pharmaceuticals (IRWD) Q1 Earnings Expected to Decline
        May 2 PRAX Wall Street Analysts See a 144.74% Upside in Praxis Precision Medicines (PRAX): Can the Stock Really Move This High?
        May 1 IRWD Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
        May 1 AXSM Axsome Therapeutics Recognizes May as Mental Health Awareness Month
        Apr 30 VNDA Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024
        Apr 30 PRTC PureTech Health plc (NASDAQ:PRTC) Q4 2023 Earnings Call Transcript
        Apr 30 DRRX DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis
        Apr 29 ACAD Acadia Pharmaceuticals is Proud to Announce the Winners of the Inaugural Rett Sibling Scholarship
        Apr 29 AXSM Axsome Therapeutics stock rises on upgrade to Overweight at Morgan Stanley
        Apr 28 ACAD ACADIA Pharmaceuticals (NASDAQ:ACAD) shareholders have endured a 37% loss from investing in the stock five years ago
        Related Industries: Biotechnology Conglomerates Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Nervous System Disorders Biopharmaceutical Schizophrenia Alzheimer's Disease Biotechnology Chemical Compounds Chronic Pain Depression Cardiovascular Disease Chronic Disease Clinical Development Depressive Disorder Gastrointestinal Gene Therapy Major Depressive Disorder Medication Medicine Organ Systems Organic Compounds Pain
        Central Nervous System Disorders

        Central Nervous System Disorders are conditions that affect the brain, spinal cord, and nerves. These disorders can cause a wide range of symptoms, including impaired movement, vision, speech, and sensation. Examples of Central Nervous System Disorders include Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke.

        Browse All Tags